loader
Please Wait
Applying Filters...
menu
    • menu

    List of Drug Master Files (DMF) of Active Pharmaceutical Ingredients (APIs) submissions by Cayman Chemical Company Inc to the U.S. FDA. Original Data : FDA Website

    Cayman Pharma s.r.o-PSE
    News
    Cayman Chemical Enhances Molecular Diagnostic Research Via PCRassays.com Deal

    05 Jun 2024

    // PRESS RELEASE

    Cayman Chemical Unveils LipidLaunch For RNA Therapy Lipid Nanoparticle Research

    02 Feb 2024

    // PRESS RELEASE

    Cayman Chemical Introduces a New Tool to Study Protein-Lipid Interactions

    20 Sep 2023

    // PRESS RELEASE

    Data Compilation
    #PharmaFlow

    Cayman 250

    Contact Supplier

    Website

    Discovery on Target

    Not Confirmed

    Book a meeting

    envelop Contact Supplier

    Latest Content by PharmaCompass

    Menu

    Cayman Chemical Company Inc

    EVENTS

    • Webinars & Exhibitions

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    SERVICES

    INSPECTIONS & REGISTRATIONS

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 1LATANOPROST DRUG SUBSTANCE

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    PharmaCompass
    Left Arrow
    Right Arrow
    Contact Cayman Chemical Company Inc and get a quotation

    Cayman Chemical Company Inc is a supplier offers 1 products (APIs, Excipients or Intermediates).

    Find a price of Latanoprost bulk with DMF, CEP, JDMF offered by Cayman Chemical Company Inc